Cannabidiol and Other Cannabinoids: Sex and Gender Differences in Use and Responses; Public Meeting

Resumo

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses." The purpose of the public meeting is to discuss potential sex (biological) and gender (psychosocial) differences in use and responses to cannabidiol (CBD) and other cannabinoids. Researchers, educators, clinicians, and patients may benefit from attending this multidisciplinary scientific conference on CBD and other cannabinoids. Presentations will address patient and healthcare provider perspectives on CBD and other cannabinoid use, sex differences in the effects of CBD and other cannabinoids, use of CBD and other cannabinoids in pregnancy, and government agency perspectives on CBD research and evaluation.